Concepedia

Denni M. Zborowski

DM

Statistics

Publications

5

Citations

323

H-Index

5

Active since

2005

Affiliations

Ontario Institute for Cancer Research(Current)

Princess Margaret Cancer Centre

University of Toronto

Denni M. Zborowski is an author at Ontario Institute for Cancer Research specializing in erlotinib therapy, medicine, and pharmacology.

Publications per year

2005–2006

5

Publications

5

Smoking History and Epidermal Growth Factor Receptor Expression as Predictors of Survival Benefit from Erlotinib for Patients with Non–Small-Cell Lung Cancer in the National Cancer Institute of Canada Clinical Trials Group Study BR.21

Gary M. Clark, Denni M. Zborowski, P. Santabárbara et al. · Clinical Lung Cancer · 2006 · 161 citations

Medicine, Oncology, Pharmacology +16

Clinical Utility of Epidermal Growth Factor Receptor Expression for Selecting Patients with Advanced Non-small Cell Lung Cancer for Treatment with Erlotinib

Gary M. Clark, Denni M. Zborowski, Jennifer Culbertson et al. · Journal of Thoracic Oncology · 2006 · 91 citations

Medicine, Oncology, Pharmacology +16

Clinical Utility of Epidermal Growth Factor Receptor Expression for Selecting Patients with Advanced Non-small Cell Lung Cancer for Treatment with Erlotinib

Gary M. Clark, Denni M. Zborowski, Jennifer Culbertson et al. · Journal of Thoracic Oncology · 2006 · 37 citations

Medicine, Oncology, Pharmacology +16

Tarceva™ (erlotinib) exposure/effects (EE) analysis from a Phase III study in advanced NSCLC: Effect of smoking on the PK of erlotinib

Marta Hamilton, Julie Wolf, Denni M. Zborowski et al. · 2005 · 17 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +17

Smoking history is more predictive of survival benefit from erlotinib for patients with non-small cell lung cancer (NSCLC) than EGFR expression

Gary M. Clark, Denni M. Zborowski, P. Santabárbara et al. · Journal of Clinical Oncology · 2005 · 17 citations

Medicine, Oncology, Pharmacology +16

1–5 of 5